B-type natriuretic peptide-guided therapy for chronic heart failure reduces all-cause mortality compared with usual care but does not affect all-cause hospitalisation or survival free of hospitalisation
Keyword(s):
Keyword(s):
2017 ◽
Vol 23
(5)
◽
pp. 382-389
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 15
(2)
◽
pp. 122-134
◽
Keyword(s):
2013 ◽
Vol 61
(10)
◽
pp. E741
Keyword(s):
2018 ◽
Vol 71
(8)
◽
pp. 951-952
◽
Keyword(s):